Intellia Therapeutics (NTLA) Receivables - Net (2015 - 2026)
Intellia Therapeutics' Receivables - Net was $7.32 million in Q2 2026, down 35.5% from $11.35 million a year earlier and down 19.8% from the prior quarter.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Receivables - Net (2015 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Net at Intellia Therapeutics came in at $9.5 million, up 11.5% from FY2024.
- Receivables - Net shows a five-year compound annual growth rate of 34.9% (FY2020 to FY2025).
- In earlier years, Receivables - Net was $8.52 million in FY2024 (-76.6%), $36.46 million in FY2023 (+867.5%), $3.77 million in FY2022 (+85.5%) and $2.03 million in FY2021 (-4.6%).
- The Q2 2026 figure marks the lowest quarterly Receivables - Net since Q3 2023.
- Compared with a year earlier, Receivables - Net was higher in three of the last eight quarters, with an average decline of 16.4%.
- The best year-over-year quarter for Receivables - Net over five years was Q4 2023 (growth of 867.5%); the worst was Q4 2024 (a decline of 76.6%).
- Per Business Quant data, NTLA's Receivables - Net in the three quarters before Q2 2026 was $9.13 million (Q1 2026), $9.5 million (Q4 2025) and $11.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Intellia Therapeutics | 1.60 Bn | 1.60 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.32 Mn |
| Mar 31, 2026 | 9.13 Mn |
| Dec 31, 2025 | 9.50 Mn |
| Sep 30, 2025 | 11.05 Mn |
| Jun 30, 2025 | 11.35 Mn |
| Mar 31, 2025 | 10.50 Mn |
| Dec 31, 2024 | 8.52 Mn |
| Sep 30, 2024 | 8.85 Mn |
| Jun 30, 2024 | 12.33 Mn |
| Mar 31, 2024 | 36.43 Mn |
| Dec 31, 2023 | 36.46 Mn |
| Sep 30, 2023 | 6.49 Mn |
| Jun 30, 2023 | 5.06 Mn |
| Mar 31, 2023 | 4.91 Mn |
| Dec 31, 2022 | 3.77 Mn |
| Sep 30, 2022 | 4.02 Mn |
| Jun 30, 2022 | 2.85 Mn |
| Mar 31, 2022 | 1.80 Mn |
| Dec 31, 2021 | 2.03 Mn |
| Sep 30, 2021 | 2.49 Mn |
API Access
Intellia Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();